Financial comparisons Neuronetics, Inc.
Equities
STIM
US64131A1051
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.650 USD | -6.25% |
|
+27.91% | +2.48% |
| Dec. 10 | Neuronetics, Inc., Q3 2025 Earnings Call, Nov 04, 2025 | |
| Nov. 04 | Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 74.5M | -57.99% | -45.69% | - | - | - | ||
| 42.88B | 14.77% | 22.64% | 17.4% | 8.55% | 2.51x | ||
| 8.35B | 27.81% | 36.72% | 17.75% | 13.59% | -0.58x | ||
| 23.88B | 16.33% | 28.89% | 7.57% | 4.81% | 1.93x | ||
| 16.75B | 11.06% | 27.04% | 18.15% | 10% | 2.14x | ||
| 27.43B | 9.17% | 16.49% | 14.77% | 5.92% | 2.84x | ||
| 5.44B | 76.75% | 27.84% | 17.48% | 12.98% | -2.02x | ||
| 6.51B | 19.8% | 26.44% | 21.95% | 11.4% | 1.1x | ||
| 19.67B | 10.13% | 16.32% | 25.59% | 6.29% | 1.6x | ||
| 5.15B | 27.22% | 34.26% | 25.97% | 18.7% | -0.29x | ||
| 5.03B | 31.77% | 35.7% | 32.58% | 22.31% | -1.13x | ||
| 18.66B | -3.9% | 11.53% | 10.82% | -2.4% | 1.76x | ||
| 2.96B | 21.56% | 30.97% | 42.82% | 13.9% | 1.17x | ||
| 4.37B | -27.97% | 13.27% | 9.61% | 4.75% | 0.95x | ||
| 4.1B | 13.8% | 30.18% | 19.07% | 10.68% | 0.23x | ||
| 6.66B | 11.82% | 16.29% | 15.6% | 10.72% | -0.1x | ||
| 2.76B | 9.81% | 28.28% | 7.75% | 4.64% | 2.34x | ||
| 3.37B | 3.36% | 15.39% | 22.59% | 7.17% | 3.17x | ||
| 36.5M | -569.23% | -256.8% | - | -36.28% | 2.13x | ||
| 442M | 8.03% | 8.49% | 19.39% | 4.7% | 1.91x | ||
| Average | 10.23B | -17.29% | 6.21% | 19.27% | 6.97% | 1.14x | |
| Weighted average by Cap. | 19.31B | 16.26% | 25.69% | 17.36% | 9.51% | 1.20x |
- Stock Market
- Equities
- STIM Stock
- Sector Neuronetics, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
















